Lung Health Study (LHS) I and III

NCT00000568 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Lung Diseases
Lung Diseases, Obstructive
Chronic Obstructive Pulmonary Disease

Interventions

BEHAVIORAL: smoking cessation
DRUG: ipratropium

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)